AEF0117

Product Specifications

CAS Number

[1610878-71-1]

UNSPSC Description

AEF0117 is a signaling-specific inhibitor of the cannabinoid receptor 1 (CB1-SSi). AEF0117 plays an important role in Cannabis use disorder (CUD)[1].

Target Antigen

Cannabinoid Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein;Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/aef0117.html

Solubility

DMF : 10 mg/mL (ultrasonic)|DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C)

Smiles

C[C@@]12[C@]3([H])[C@](CC=C1C[C@H](CC2)OCC4=CC=C(C=C4)OC)([H])[C@@]5([H])[C@](CC3)([C@H](CC5)C(C)=O)C

Molecular Weight

436.63

References & Citations

[1]Margaret Haney, et al. Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials. Nat Med. 2023 Jun;29(6):1487-1499.

Shipping Conditions

Room Temperature

Clinical Information

Phase 2

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

MBS1327105-01 0.02 mg (E-Coli)

Recombinant Shewanella sp. Thymidylate kinase (tmk)

View Details

MBS1327105-02 0.1 mg (E-Coli)

Recombinant Shewanella sp. Thymidylate kinase (tmk)

View Details

MBS1327105-03 0.02 mg (Yeast)

Recombinant Shewanella sp. Thymidylate kinase (tmk)

View Details

MBS1327105-04 0.1 mg (Yeast)

Recombinant Shewanella sp. Thymidylate kinase (tmk)

View Details

MBS1327105-05 0.02 mg (Baculovirus)

Recombinant Shewanella sp. Thymidylate kinase (tmk)

View Details

MBS1327105-06 0.02 mg (Mammalian-Cell)

Recombinant Shewanella sp. Thymidylate kinase (tmk)

View Details